{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:14:30Z","timestamp":1790745270219,"version":"4.1.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Acute anaphylaxis to small molecule drugs is largely considered to be antibody-mediated with immunogloblin E (IgE) and mast cell activation being key. More recently, a role for drug-reactive immunoglobulin G (IgG) with neutrophil activation has also been suggested, at least in reactions to neuromuscular blocking agents (NMBAs). However, the mast cell receptor MRGPRX2 has also been highlighted as a possible triggering mechanism in acute anaphylaxis to many clinically used drugs. Significantly, MRGPRX2 activation is not dependent upon the presence of drug-recognising antibody. Given the reasonable assumption that MRGPRX2 is expressed in all individuals, the corollary of this is that in theory, anybody could respond detrimentally to triggering drugs (recently suggested to be around 20% of a drug-like compound library). But this clearly is not the case, as the incidence of acute drug-induced anaphylaxis is very low. In this mini-review we consider antibody-dependent and -independent mechanisms of mast cell activation by small molecule drugs with a focus on the MRGPRX2 pathway. Moreover, as a juxtaposition to these adverse drug actions, we consider how increased understanding of the role of MRGPRX2 in anaphylaxis is important for future drug development and can complement exploration of this receptor as a drug target in broader clinical settings.<\/jats:p>","DOI":"10.3389\/fimmu.2021.688930","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T05:32:52Z","timestamp":1637299972000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Antibody or Anybody? Considering the Role of MRGPRX2 in Acute Drug-Induced Anaphylaxis and as a Therapeutic Target"],"prefix":"10.3389","volume":"12","author":[{"given":"Graham A.","family":"Mackay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya A.","family":"Fernandopulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"McComish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Soeding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.04.015","article-title":"Anaesthesia, Surgery, and Life-Threatening Allergic Reactions: Management and Outcomes in the 6th National Audit Project (NAP6)","volume":"121","author":"Harper","year":"2018","journal-title":"Br J Anaesth"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/all.12426","article-title":"Fatal Anaphylaxis With Neuromuscular Blocking Agents: A Risk Factor and Management Analysis","volume":"69","author":"Reitter","year":"2014","journal-title":"Allergy"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.01.031","article-title":"Molecular Mechanisms and Pathophysiology of Perioperative Hypersensitivity and Anaphylaxis: A Narrative Review","volume":"123","author":"Ebo","year":"2019","journal-title":"Br J Anaesth"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.02.013","article-title":"Mechanisms of Human Drug-Induced Anaphylaxis","volume":"147","author":"Bruhns","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jaci.2021.03.049","article-title":"Multifaceted MRGPRX2: New Insight Into the Role of Mast Cells in Health and Disease","volume":"148","author":"Roy","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.027","article-title":"Mas-Related G Protein-Coupled Receptor X2 and Its Activators in Dermatologic Allergies","volume":"147","author":"K\u00fchn","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11882-020-00979-5","article-title":"Mast Cell-Specific MRGPRX2: A Key Modulator of Neuro-Immune Interaction in Allergic Diseases","volume":"21","author":"Thapaliya","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature14022","article-title":"Identification of a Mast-Cell-Specific Receptor Crucial for Pseudo-Allergic Drug Reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.03.003","article-title":"Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema","volume":"5","author":"Sinert","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312524","article-title":"A Randomized Trial of Icatibant in ACE-Inhibitor-Induced Angioedema","volume":"372","author":"Ba\u015f","year":"2015","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e00547","DOI":"10.1002\/prp2.547","article-title":"Mrgx2 is a Promiscuous Receptor for Basic Peptides Causing Mast Cell Pseudo-Allergic and Anaphylactoid Reactions","volume":"7","author":"Grimes","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/1547691X.2021.1877375","article-title":"In Vitro Prediction of In Vivo Pseudo-Allergenic Response via MRGPRX2","volume":"18","author":"John","year":"2021","journal-title":"J Immunotoxicol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.02.015","article-title":"Human IgE-Independent Systemic Anaphylaxis","volume":"137","author":"Finkelman","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"eaat1479s","DOI":"10.1126\/scitranslmed.aat1479","article-title":"An Igg-Induced Neutrophil Activation Pathway Contributes to Human Drug-Induced Anaphylaxis","volume":"11","author":"J\u00f6nsson","year":"2019","journal-title":"Sci Transl Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.06.003","article-title":"The Pathophysiology of Anaphylaxis","volume":"140","author":"Reber","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"eaaw6433","DOI":"10.1126\/science.aaw6433","article-title":"Identification of a T Follicular Helper Cell Subset That Drives Anaphylactic IgE","volume":"365","author":"Gowthaman","year":"2019","journal-title":"Science"},{"key":"B17","unstructured":"Drug Allergy: Diagnosis and Management. National Institute for Health and Care Excellence (NICE), Clinical Guideline [CG183]"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.10.006","article-title":"Immunoglobulin E Cross-Linking or MRGPRX2 Activation: Clinical Insights From Rocuronium Hypersensitivity","volume":"126","author":"Ebo","year":"2021","journal-title":"Br J Anaesth"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00707-3","article-title":"Serum Tryptase Cannot Differentiate Vancomycin-Induced Anaphylaxis From Red Man Syndrome","volume":"39","author":"Noguchi","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00299","article-title":"Heterogeneity of Human Mast Cells With Respect to MRGPRX2 Receptor Expression and Function","volume":"13","author":"Varricchi","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200004000-00026","article-title":"Mechanisms of Nonimmunological Histamine and Tryptase Release From Human Cutaneous Mast Cells","volume":"92","author":"Veien","year":"2000","journal-title":"Anesthesiology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.10.027","article-title":"Principles, Potential, and Limitations of Ex Vivo Basophil Activation by Flow Cytometry in Allergology: A Narrative Review","volume":"147","author":"Ebo","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/all.14213","article-title":"The Pseudoallergen Receptor MRGPRX2 on Peripheral Blood Basophils and Eosinophils: Expression and Function","volume":"75","author":"Wedi","year":"2020","journal-title":"Allergy"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/all.14252","article-title":"Surface Expression of MRGPRX2 on Resting Basophils: An Area of Controversy","volume":"75","author":"Sabato","year":"2020","journal-title":"Allergy"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85538","article-title":"Different Activation Signals Induce Distinct Mast Cell Degranulation Strategies","volume":"126","author":"Gaudenzio","year":"2016","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138448","article-title":"Bruton\u2019s Tyrosine Kinase Inhibition Effectively Protects Against Human IgE-Mediated Anaphylaxis","volume":"130","author":"Dispenza","year":"2020","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.12.987","article-title":"Short-Term Ibrutinib Therapy Suppresses Skin Test Responses and Eliminates IgE-Mediated Basophil Activation in Adults With Peanut or Tree Nut Allergy","volume":"141","author":"Dispenza","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/cea.12675","article-title":"Mast Cells in Asthma\u2013State of the Art","volume":"46","author":"Bradding","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1997.77.4.1033","article-title":"Mast Cells","volume":"77","author":"Metcalfe","year":"1997","journal-title":"Physiol Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.7150\/thno.46719","article-title":"Mast Cells as a Unique Hematopoietic Lineage and Cell System: From Paul Ehrlich\u2019s Visions to Precision Medicine Concepts","volume":"10","author":"Valent","year":"2020","journal-title":"Theranostics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3445","article-title":"Immunological Genome Project Consortium. Expression Profiling of Constitutive Mast Cells Reveals a Unique Identity Within the Immune System","volume":"17","author":"Dwyer","year":"2016","journal-title":"Nat Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.01.012","article-title":"Human Mast Cell Proteome Reveals Unique Lineage, Putative Functions, and Structural Basis for Cell Ablation","volume":"52","author":"Plum","year":"2020","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13732","article-title":"Gene Signatures From Scrna-Seq Accurately Quantify Mast Cells in Biopsies in Asthma","volume":"50","author":"Jiang","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.154.6.2855","article-title":"Human Heart Mast Cells. Isolation, Purification, Ultrastructure, and Immunologic Characterization","volume":"154","author":"Patella","year":"1995","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-Related Gene X2 on Mast Cells Is Upregulated in the Skin of Patients With Severe Chronic Urticaria","volume":"134","author":"Fujisawa","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2021.113003","article-title":"Peripheral Blood Cultured Mast Cells: Phenotypic and Functional Outcomes of Different Culture Protocols","volume":"492","author":"Elst","year":"2021","journal-title":"J Immunol Methods"},{"key":"B37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/cells10010102","article-title":"Thymic Stromal Lymphopoietin Promotes MRGPRX2-Triggered Degranulation of Skin Mast Cells in a STAT5-Dependent Manner With Further Support From JNK","volume":"10","author":"Babina","year":"2021","journal-title":"Cells"},{"key":"B38","article-title":"Mast Cells and Their Microenvironment: The Influence of Fibronectin and Fibroblasts on the Functional Repertoire of Rat Basophilic Leukemia Cells","volume":"64","author":"Swieter","year":"1993","journal-title":"J Periodontol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1089\/ten.TEA.2020.0142","article-title":"Dermal Extracellular Matrix-Derived Hydrogels as an In Vitro Substrate to Study Mast Cell Maturation","volume":"27","author":"Ozpinar","year":"2020","journal-title":"Tissue Eng Part A"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0698-3","article-title":"Upregulation of Mas-Related G Protein Coupled Receptor X2 in Asthmatic Lung Mast Cells and its Activation by the Novel Neuropeptide Hemokinin-1","volume":"19","author":"Manorak","year":"2018","journal-title":"Respir Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.076","article-title":"Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target","volume":"160","author":"Chen","year":"2021","journal-title":"Gastroenterology"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-27820-5_9","article-title":"Anaphylaxis in Mastocytosis (Chapter 9)","volume-title":"Mastocytosis: A Comprehensive Guide","author":"G\u00fclen","year":"2020"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2017.07.022","article-title":"Management Around Invasive Procedures in Mastocytosis","volume":"199","author":"Hermans","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.05.042","article-title":"Expression of MRGPRX2 in Skin Mast Cells of Patients With Maculopapular Cutaneous Mastocytosis","volume":"9","author":"Deepak","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.02.008","article-title":"Risk Factor Analysis of Anaphylactic Reactions in Patients With Systemic Mastocytosis","volume":"5","author":"G\u00fclen","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.668962","article-title":"Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents and Fluoroquinolones","volume":"12","author":"Elst","year":"2021","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-019-0288-6","article-title":"Rapid Identification of Human Mast Cell Degranulation Regulators Using Functional Genomics Coupled to High-Resolution Confocal Microscopy","volume":"15","author":"Folkerts","year":"2020","journal-title":"Nat Protoc"},{"key":"B48","doi-asserted-by":"publisher","first-page":"S0091","DOI":"10.1016\/j.jaci.2021.07.027","article-title":"A Novel Approach for Studying Mast Cell-Driven Disorders: Mast Cells Derived From Induced Pluripotent Stem Cells","volume":"6","author":"Luo","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2017.08.008","article-title":"Mast Cells Derived From Human Induced Pluripotent Stem Cells are Useful for Allergen Tests","volume":"67","author":"Igarashi","year":"2018","journal-title":"Allergol Int"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2131\/jts.44.789","article-title":"Human Induced Pluripotent Stem Cell-Derived Mast Cells Useful for In Vitro Mast Cell Activation Assay Exhibiting Phenotypes and Morphological Characteristics of Human Mast Cells","volume":"44","author":"Ikuno","year":"2019","journal-title":"J Toxicol Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701793","article-title":"Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human Beta-Defensin-3, and Icatibant","volume":"201","author":"Alkanfari","year":"2018","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801227","article-title":"Angiogenic Host Defense Peptide AG-30\/5C and Bradykinin B2 Receptor Antagonist Icatibant Are G Protein Biased Agonists for MRGPRX2 in Mast Cells","volume":"202","author":"Roy","year":"2019","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.09.017","article-title":"MRGPRX2 is the Codeine Receptor of Human Skin Mast Cells: Desensitization Through Beta-Arrestin and Lack of Correlation With the Fc\u03b5RI Pathway","volume":"141","author":"Babina","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215247","article-title":"Identification of Gain and Loss of Function Missense Variants in MRGPRX2\u2019s Transmembrane and Intracellular Domains for Mast Cell Activation by Substance P","volume":"20","author":"Chompunud Na Ayudhya","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010156","article-title":"MRGPRX2 Activation by Rocuronium: Insights From Studies With Human Skin Mast Cells and Missense Variants","volume":"10","author":"Chompunud Na Ayudhya","year":"2021","journal-title":"Cells"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N Engl J Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.03.046","article-title":"PGE2 Deficiency Predisposes to Anaphylaxis by Causing Mast Cell Hyperresponsiveness","volume":"146","author":"Rastogi","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.04.044","article-title":"Management of Suspected Immediate Perioperative Allergic Reactions: An International Overview and Consensus Recommendations","volume":"123","author":"Garvey","year":"2019","journal-title":"Br J Anaesth"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13801","article-title":"MRGPRX2 Activation in Mast Cells by Neuromuscular Blocking Agents and Other Agonists: Modulation by Sugammadex","volume":"51","author":"Fernandopulle","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.11.025","article-title":"Quercetin Inhibits Mrgprx2-Induced Pseudo-Allergic Reaction via Plc\u03b3-IP3R Related Ca2+ Fluctuations","volume":"66","author":"Ding","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00703","article-title":"Osthole, a Natural Plant Derivative Inhibits MRGPRX2 Induced Mast Cell Responses","volume":"11","author":"Callahan","year":"2020","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/molecules25051028","article-title":"Protective Effect of Genistein Against Compound 48\/80 Induced Anaphylactoid Shock via Inhibiting MAS Related G Protein-Coupled Receptor X2 (MRGPRX2)","volume":"25","author":"Kumar","year":"2020","journal-title":"Molecules"},{"key":"B63","doi-asserted-by":"publisher","first-page":"173104","DOI":"10.1016\/j.ejphar.2020.173104","article-title":"A Novel MRGPRX2-Targeting Antagonistic DNA Aptamer Inhibits Histamine Release and Prevents Mast Cell-Mediated Anaphylaxis","volume":"878","author":"Suzuki","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.2AB1018-405R","article-title":"Novel MRGPRX2 Antagonists Inhibit Ige-Independent Activation of Human Umbilical Cord Blood-Derived Mast Cells","volume":"106","author":"Ogasawara","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.559589","article-title":"Amelioration of Compound 48\/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide","volume":"11","author":"Dondalska","year":"2020","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.coph.2018.05.004","article-title":"Mast Cell Activators as Novel Immune Regulators","volume":"41","author":"Johnson-Weaver","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2019.06.003","article-title":"A Connective Tissue Mast-Cell-Specific Receptor Detects Bacterial Quorum-Sensing Molecules and Mediates Antibacterial Immunity","volume":"26","author":"Pundir","year":"2019","journal-title":"Cell Host Microbe"},{"key":"B68","doi-asserted-by":"publisher","first-page":"eaav0216","DOI":"10.1126\/sciadv.aav0216","article-title":"MRGPR-Mediated Activation of Local Mast Cells Clears Cutaneous Bacterial Infection and Protects Against Reinfection","volume":"5","author":"Arifuzzaman","year":"2019","journal-title":"Sci Adv"},{"key":"B69","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/JLB.3MA1219-210RR","article-title":"A Humanized Mouse Model to Study Mast Cells Mediated Cutaneous Adverse Drug Reactions","volume":"107","author":"Mencarelli","year":"2020","journal-title":"J Leukoc Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.688930\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T20:41:38Z","timestamp":1673815298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.688930\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2021.688930"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.688930","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]},"article-number":"688930"}}